The nation of Zimbabwe has turned down a major American health deal valued at $367m (272 million pounds) over five years because of the United States' insistence on confidential information.
This move became public following a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the deal was "unbalanced".
A government spokesperson later clarified that the US was demanding access to health data for scientific study and commercial gain but was unwilling to guarantee the benefits from any future treatments.
"We will now turn to the challenging and unfortunate process of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had donated over $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for further negotiations to find a agreement suitable to all parties so the nation's vital HIV programme can proceed.
Wider Background
Zimbabwe's decision follows a similar case in neighbouring Kenya, where a court halted a related deal with the US following concerns were raised about the security of Kenyans' health data.
Since resuming office last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the American government, but Trump stated its spending was "inefficient" and his government was seeking direct bilateral deals to boost transparency and accountability.
As per statements, Sixteen nations in Africa have to date signed similar health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The money for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation might have yielded extraordinary benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment through US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its genetic material and health information for a long time, without any corresponding assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"Effectively, our nation would supply the raw materials for medical research with no certainty that the end products would be available to our population should a future pandemic arise."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting frameworks already set up via the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing framework created to manage potential pandemics.
"This mechanism is intended to ensure that when a country contributes its data, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised solely by those with the resources to develop them."
These objections regarding the US deal "must not be interpreted as opposition to America," he added.
"We encourage ongoing discussions with our American counterparts on how subsequent collaboration might be designed in a manner that honours the sovereignty and interests of each country."
Medical Community Response
A leading public health body stated it acknowledged the government's concerns, but suggested that talks should continue given that much of the country's Aids initiatives were funded by international support.
"In cases where technical issues arise, including those involving data governance or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," the group added.
This impasse underscores the complex debate between receiving crucial international aid and safeguarding local interests in an increasingly interconnected world.